DBV Technologies (DBVT) EPS (Basic) (2020 - 2026)
DBV Technologies (DBVT) posted quarterly EPS (Basic) of -$0.12 for Q2 2026, up 62.69% year-on-year from -$0.07 in Q2 2025, and down 4.6% on a QoQ basis from -$0.11 in Q1 2026.
DBV Technologies (DBVT) EPS (Basic) (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported EPS (Basic) for 7 consecutive years, with -$0.12 the latest figure, recorded in Q2 2026.
- Quarterly EPS (Basic) rose 62.69% year-over-year to -$0.12 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$0.41 (up 55.42% YoY) and the FY2025 annual result came in at -$1.05, up 10.36% from the prior year.
- EPS (Basic) retreated to -$0.12 in Q2 2026 per DBVT's latest filing, from -$0.11 in the prior quarter.
- Over the last five years, EPS (Basic) for DBVT reached as high as -$0.11 in Q1 2026 and fell as low as -$5.07 in Q4 2022.
- A 5-year average of -$1.6 and a median of -$1.65 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) slumped 103.69% — and 2025, when it soared 90.71%.
- Year by year, EPS (Basic) stood at -$5.07 in 2022, then soared by 76.81% to -$1.18 in 2023, then soared by 79.82% to -$0.24 in 2024, then sank by 35.36% to -$0.32 in 2025, then surged by 63.8% to -$0.12 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.12, -$0.11, and -$0.32 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | -0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.12 |
| Mar 31, 2026 | -0.11 |
| Dec 31, 2025 | -0.32 |
| Sep 30, 2025 | -0.24 |
| Jun 30, 2025 | -0.31 |
| Mar 31, 2025 | -0.26 |
| Dec 31, 2024 | -0.24 |
| Sep 30, 2024 | -1.58 |
| Jun 30, 2024 | -1.72 |
| Mar 31, 2024 | -2.84 |
| Dec 31, 2023 | -1.18 |
| Sep 30, 2023 | -1.74 |
| Jun 30, 2023 | -2.57 |
| Mar 31, 2023 | -2.19 |
| Dec 31, 2022 | -5.07 |
| Sep 30, 2022 | -1.84 |
| Jun 30, 2022 | -3.49 |
| Mar 31, 2022 | -3.04 |
| Dec 31, 2021 | -2.49 |
| Sep 30, 2021 | -4.37 |